UTRS (Minerva Surgical) Marketable Securities: $0.00 Mil (As of Sep. 2023)


What is Minerva Surgical Marketable Securities?

Minerva Surgical UTRS -99.00% Marketable Securities is $0.00 Mil as of Sep. 2023.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Minerva Surgical's Marketable Securities for the quarter that ended in Sep. 2023 was $0.00 Mil.

Minerva Surgical  (OTCPK:UTRS) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Minerva Surgical Marketable Securities Related Terms

Minerva Surgical Marketable Securities Historical Data

* Premium members only.

The historical data trend for Minerva Surgical's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Minerva Surgical Marketable Securities Chart

Minerva Surgical Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Marketable Securities
0.00 0.00 0.00 0.00

Minerva Surgical Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Minerva Surgical Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $0.00 Mil mean?
Minerva Surgical (UTRS) has a Marketable Securities of $0.00 Mil as of Sep. 2023. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Minerva Surgical and its competitors.
Is Minerva Surgical's Marketable Securities too high?
Minerva Surgical's current Marketable Securities is $0.00 Mil.
How does Minerva Surgical's Marketable Securities compare to PAVM and ELUT?
Minerva Surgical's Marketable Securities of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Minerva Surgical and its competitors. Minerva Surgical's current Marketable Securities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minerva Surgical stock overvalued right now?
Minerva Surgical (UTRS) has a current Marketable Securities of $0.00 Mil. The current Marketable Securities is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Minerva Surgical (UTRS), the current Marketable Securities is $0.00 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Minerva Surgical Business Description

Address 4255 Burton Drive, Santa Clara, CA, USA, 95054
Minerva Surgical Inc is a medical device company that develops therapeutic devices that treat abnormal uterine bleeding in a minimally invasive manner. The Company operates and manages its business as one reportable and operating segment, which is the business of research, development, and sale of therapeutic devices for abnormal uterine bleeding treatment.